DIM-C-pPhOH,99.05%
产品编号:Bellancom-112055| CAS NO:151358-47-3| 分子式:C23H18N2O| 分子量:338.40
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
DIM-C-pPhOH
| 产品介绍 | DIM-C-pPhOH 是核受体 4A1 (NR4A1) 拮抗剂。DIM-C-pPhOH 抑制癌细胞的生长和 mTOR 信号传导,诱导细胞凋亡和细胞应激。DIM-C-pPhOH 可降低细胞增殖,对 ACHN 细胞和 786-O 细胞的 IC50 值分别为 13.6 μM 和 13.0 μM。 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物活性 | DIM-C-pPhOH is a nuclear receptor 4A1 (NR4A1) antagonist. DIM-C-pPhOH inhibits cancer cell growth and mTOR signaling, induce apoptosis and cellular stress. DIM-C-pPhOH reduces cell proliferation with IC50 values of 13.6 μM and 13.0 μM for ACHN cells and 786-O cells, respectively. | ||||||||||||||||||||||||
| 体外研究 |
DIM-C-pPhOH (7.5-20 μM; 24 hours; ACHN and 786-O cells) treatment significantly decreases cell proliferation. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation Assay
Apoptosis Analysis
Western Blot Analysis
|
||||||||||||||||||||||||
| 体内研究 (In Vivo) |
DIM-C-pPhOH (30 mg/kg; oral gavage; daily; for 50 days; male athymic nude mice) treatment results in a significant inhibition of tumor growth. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||||
| 体内研究 |
DIM-C-pPhOH (30 mg/kg; oral gavage; daily; for 50 days; male athymic nude mice) treatment results in a significant inhibition of tumor growth. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||||
| 体内研究 |
DIM-C-pPhOH (30 mg/kg; oral gavage; daily; for 50 days; male athymic nude mice) treatment results in a significant inhibition of tumor growth. 西域 has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||||||||||
| 性状 | Solid | ||||||||||||||||||||||||
| 溶解性数据 |
In Vitro:
DMSO : 125 mg/mL (369.39 mM; ultrasonic and warming and heat to 60°C) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
| ||||||||||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
| 储存方式 |
| ||||||||||||||||||||||||
| 参考文献 |
|

浙公网安备 33010802013016号